Surmodics, Inc. is a leader in the development of advanced medical technologies, particularly focusing on interventional products and performance coatings. Their flagship offerings include the Pounce™ Thrombectomy System and the Pounce™ LP Thrombectomy System, which utilize innovative dual-basket technology to effectively remove arterial clots in various vessel sizes. These systems are designed to enhance the efficiency of clot removal procedures, addressing both acute and chronic conditions in peripheral arteries. Additionally, the Pounce™ Venous Thrombectomy System employs a dynamic, collapsible basket to extract wall-adherent venous clots, streamlining the treatment process without the need for thrombolytics. 

In the realm of performance coatings, Surmodics specializes in customized hydrophilic, hemocompatible, and drug-delivery coatings for intravascular medical devices. Their Preside™ Hydrophilic Coatings are engineered to navigate complex anatomical structures, enhancing the performance of devices used in neuro, coronary, and peripheral applications. Furthermore, Surmodics is recognized for its contributions to in vitro diagnostics, providing essential chemical components that support the development of sensitive and robust diagnostic technologies. With a commitment to innovation and quality, Surmodics continues to partner with a diverse range of medical device manufacturers, leveraging over 40 years of expertise in surface technology and product development.

United States

Surmodics is the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic (IVD) immunoassay tests and microarrays. Surmodics is pursuing highly differentiated medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements.

Surmodics, Inc.

Company Details